Zanou, Nadège https://orcid.org/0000-0001-6626-3127
Dridi, Haikel https://orcid.org/0000-0001-9533-7367
Reiken, Steven
Imamura de Lima, Tanes
Donnelly, Chris https://orcid.org/0000-0002-5392-7876
De Marchi, Umberto https://orcid.org/0000-0002-6011-5446
Ferrini, Manuele https://orcid.org/0000-0001-8291-6618
Vidal, Jeremy
Sittenfeld, Leah
Feige, Jerome N. https://orcid.org/0000-0002-4751-264X
Garcia-Roves, Pablo M. https://orcid.org/0000-0002-8371-2067
Lopez-Mejia, Isabel C. https://orcid.org/0000-0001-5918-0227
Marks, Andrew R.
Auwerx, Johan https://orcid.org/0000-0002-5065-5393
Kayser, Bengt https://orcid.org/0000-0002-9776-7501
Place, Nicolas https://orcid.org/0000-0001-9044-0621
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF Grant n° IZK0Z3_173941)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF Grant n° 194964)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Ambizione PZ00P3_168077)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PRIMA PR00P3_193166)
Université de Lausanne (Subside Tremplin, Relève académique)
Universidade de Brasília (FAPESP (2019/11171-7))
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Grant PI15/00701)
Funder: European Regional Development Fund ‘A way to build Europe’’
Foundation for the National Institutes of Health (R01HL145473)
Foundation for the National Institutes of Health (R01DK118240)
Foundation for the National Institutes of Health (R01HL142903)
Foundation for the National Institutes of Health (R01HL061503)
Foundation for the National Institutes of Health (R01HL140934)
Foundation for the National Institutes of Health (R01AR070194)
Stiftung für die Erforschung der Muskelkrankheiten
Funders: - Ecole polytechnique fédérale de Lausanne - Fondation Marcel Levaillant
Article History
Received: 21 July 2020
Accepted: 18 November 2021
First Online: 10 December 2021
Competing interests
: U.D.M. and J.N.F. are employees of Nestlé Research, which is part of the Société des Produits Nestlé SA. A.R.M. is chair of the SAB and holds stock in ARMGO Pharma Inc., a biotech company developing drugs targeting RyR channel leak. The remaining authors declare no competing interests.